2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase EARLY_PHASE1
1
Status
Unknown
3
Terminated
1
Sponsor Class
OTHER
4
Study Type
Interventional
3
Observational
1
Sponsor
Cancer Type
Gynecologic
64
Gastrointestinal
60
Thoracic
4
Other solid neoplasm
4
Genitourinary
3
Sarcoma
2
Other neoplasm
2
Tumor-Agnostic
1
Conditions
Stomach Neoplasms
3
Ovarian Neoplasms
3
Peritoneal Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Pleural Effusion
1
Pelvic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Liposarcoma
1
Gastrointestinal Neoplasms
1
Gallbladder Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Ascites
1
Appendiceal Neoplasms
1
Interventions
Carboplatin
1167
Cisplatin
889
Pemetrexed
845
pembrolizumab
622
Paclitaxel
608
Docetaxel
539
Gemcitabine
428
Radiotherapy
390
Erlotinib Hydrochloride
381
Nivolumab
344
Bevacizumab
337
Etoposide
296
durvalumab
264
Drug Therapy
260
osimertinib
236
atezolizumab
224
Radiosurgery
194
Gefitinib
186
Vinorelbine
149
Magnetic Resonance Spectroscopy
131
Ipilimumab
129
130-nm albumin-bound paclitaxel
124
Cetuximab
113
Blood Specimen Collection
106
anlotinib
105
tislelizumab
103
Topotecan
103
Specimen Handling
102
Surgical Procedures, Operative
101
Cyclophosphamide
101
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Hyperthermic Intraperitoneal Chemotherapy
×
Thoracic
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled
NCT03210298
2019-10-08
PIPACRegis
University of Magdeburg
Unknown
1,000 enrolled
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled